Henkel buys stake in Wella

Related tags Stock

German pharmaceutical group Henkel has acquired a stake of 6.86 per cent in the
share capital of Wella. Through a subsidiary, the group obtained
4.99 per cent of the common shares and 10.38 per cent of the
preferred non voting shares.

German pharmaceutical group Henkel​ has acquired a stake of 6.86 per cent in the share capital of Wella. Through a subsidiary the group obtained 4.99 per cent of the common shares and 10.38 per cent of the preferred non voting shares.

In a statement Henkel said 'in view of the current stock market conditions Henkel regards this shareholding as an interesting investment. '​ The Henkel group operates in three business areas Home Care, Personal Care, and Adhesives, Sealants and Surface Treatment. In fiscal 2002, the Henkel Group generated sales of 9.66 billion euros and an operating profit (EBIT) of 666 million euros.

Related topics Formulation & Science Hair Care

Related news

Related products

Calendula Cellular Elixir: Alchemy in a cell

Calendula Cellular Elixir: Alchemy in a cell

Content provided by Naolys | 24-Apr-2024 | Product Brochure

Get ready to experience a cellular evolution in skincare with InnerLift Calendula's advanced Plant Cell biotechnology.

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Related suppliers

Follow us

Products

View more

Webinars

Podcast

Beauty 4.0 Podcast